Solasia Pharma K.K.
TSE:4597.T
46 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 60 | 11 | 15 | 73 | 309 | 220 | 607 | 295 | 76 | 113 | 276 | 5 | 186 | 91 | 167 | 47 | 84 | 156 | 1,019 | 160 | 69 | 61 | 208 | 26 | 76 | 7 | 1.344 | 403.874 | 2.053 | 3.579 | 300 | 0 | 1.319 | 200 | 24.564 | 1.902 |
| Cost of Revenue
| 92 | 104 | 131 | 31 | 148 | 91 | 298 | 70 | 31 | 30 | 28 | 0 | 115 | 41 | 109 | 35 | 21 | 43 | 18 | 28 | 19 | 0 | 142 | 0 | 65 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -32 | -93 | -116 | 42 | 161 | 129 | 309 | 225 | 45 | 83 | 248 | 5 | 71 | 50 | 58 | 12 | 63 | 113 | 1,001 | 132 | 50 | 61 | 66 | 26 | 11 | 1 | 1.344 | 403.874 | 2.053 | 3.579 | 300 | 0 | 1.319 | 200 | 24.564 | 1.902 |
| Gross Profit Ratio
| -0.533 | -8.455 | -7.733 | 0.575 | 0.521 | 0.586 | 0.509 | 0.763 | 0.592 | 0.735 | 0.899 | 1 | 0.382 | 0.549 | 0.347 | 0.255 | 0.75 | 0.724 | 0.982 | 0.825 | 0.725 | 1 | 0.317 | 1 | 0.145 | 0.143 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 147 | 76 | 95 | 116 | 99 | 93 | 117 | 418 | 170 | 177 | 23 | 204 | 359 | 258 | 925 | 283 | 463 | 255 | 422 | 260 | 211 | 243 | 570 | 410 | 331 | 151 | 382.46 | 105.297 | 158.925 | 126.836 | 120.652 | 102.622 | 95.726 | 156.418 | 138.902 | 116.627 |
| General & Administrative Expenses
| 158 | 232 | 263 | 250 | 279 | 280 | 712 | 529 | 503 | 505 | 581 | 502 | 431 | 434 | 1,347 | 360 | 333 | 391 | 755 | 447 | 354 | 311 | 378 | 230 | 278 | 174 | 204.107 | 169.945 | 152.888 | 120.074 | 185.875 | 98.976 | 104.928 | 98.599 | 133.483 | 96.854 |
| Selling & Marketing Expenses
| -34 | -93 | -122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 124 | 139 | 141 | 250 | 279 | 280 | 712 | 529 | 503 | 505 | 581 | 502 | 431 | 434 | 1,347 | 360 | 333 | 391 | 755 | 447 | 354 | 311 | 378 | 230 | 278 | 174 | 204.107 | 169.945 | 152.888 | 120.074 | 185.875 | 98.976 | 104.928 | 98.599 | 133.483 | 96.854 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0 | 0 |
| Operating Expenses
| 271 | 215 | 236 | 366 | 378 | 373 | 829 | 947 | 673 | 682 | 604 | 706 | 790 | 692 | 2,272 | 643 | 796 | 646 | 1,177 | 707 | 565 | 554 | 948 | 640 | 609 | 325 | 586.567 | 275.242 | 311.813 | 246.91 | 306.527 | 201.598 | 200.654 | 255.017 | 272.385 | 213.481 |
| Operating Income
| -303 | -308 | -352 | -324 | -217 | -245 | -519 | -723 | -629 | -600 | -356 | -701 | -720 | -642 | -2,214 | -633 | -734 | -534 | -177 | -575 | -516 | -494 | -882 | -615 | -598 | -325 | -585.222 | 128.631 | -309.76 | -243.331 | -6.527 | -201.599 | -199.333 | -55.017 | -247.821 | -211.579 |
| Operating Income Ratio
| -5.05 | -28 | -23.467 | -4.438 | -0.702 | -1.114 | -0.855 | -2.451 | -8.276 | -5.31 | -1.29 | -140.2 | -3.871 | -7.055 | -13.257 | -13.468 | -8.738 | -3.423 | -0.174 | -3.594 | -7.478 | -8.098 | -4.24 | -23.654 | -7.868 | -46.429 | -435.433 | 0.318 | -150.882 | -67.989 | -0.022 | 0 | -151.124 | -0.275 | -10.089 | -111.24 |
| Total Other Income Expenses Net
| -5 | -10 | 2 | -9 | 14 | -2 | 3 | -16 | 3 | -6 | -2 | 1 | -13 | -8 | -17 | -12 | -12 | -3 | 1 | -9 | -21 | -6 | -14 | -7 | -2 | -1 | -0.605 | -0.669 | -1.262 | -4.065 | -17.822 | -2.068 | -6.493 | -5.777 | -5.702 | -3.475 |
| Income Before Tax
| -308 | -318 | -350 | -333 | -203 | -247 | -519 | -739 | -626 | -606 | -358 | -700 | -733 | -650 | -2,231 | -645 | -746 | -537 | -176 | -584 | -537 | -499 | -896 | -622 | -600 | -325 | -585.828 | 127.962 | -311.022 | -247.396 | -24.349 | -203.667 | -205.828 | -60.794 | -253.523 | -215.054 |
| Income Before Tax Ratio
| -5.133 | -28.909 | -23.333 | -4.562 | -0.657 | -1.123 | -0.855 | -2.505 | -8.237 | -5.363 | -1.297 | -140 | -3.941 | -7.143 | -13.359 | -13.723 | -8.881 | -3.442 | -0.173 | -3.65 | -7.783 | -8.18 | -4.308 | -23.923 | -7.895 | -46.429 | -435.884 | 0.317 | -151.496 | -69.124 | -0.081 | 0 | -156.049 | -0.304 | -10.321 | -113.067 |
| Income Tax Expense
| -8 | -8 | -7 | -2 | -6 | -6 | -19 | 61 | 5 | 8 | 9 | 15 | 5 | 5 | -40 | 19 | -5 | -6 | 19 | -4 | -4 | 61 | -8 | -5 | -5 | -5 | 10.26 | -6.381 | -6.374 | -6.307 | -8.124 | -7.265 | -5.771 | 0.957 | -65.663 | 16.317 |
| Net Income
| -300 | -310 | -344 | -331 | -196 | -241 | -500 | -800 | -631 | -614 | -367 | -716 | -738 | -656 | -2,190 | -665 | -740 | -531 | -195 | -579 | -532 | -560 | -889 | -617 | -595 | -320 | -596.087 | 134.343 | -304.648 | -241.089 | -16.225 | -196.402 | -200.057 | -61.752 | -187.86 | -231.372 |
| Net Income Ratio
| -5 | -28.182 | -22.933 | -4.534 | -0.634 | -1.095 | -0.824 | -2.712 | -8.303 | -5.434 | -1.33 | -143.2 | -3.968 | -7.209 | -13.114 | -14.149 | -8.81 | -3.404 | -0.191 | -3.619 | -7.71 | -9.18 | -4.274 | -23.731 | -7.829 | -45.714 | -443.517 | 0.333 | -148.392 | -67.362 | -0.054 | 0 | -151.673 | -0.309 | -7.648 | -121.647 |
| EPS
| -1.57 | -1.78 | -2.04 | -1.97 | -1.17 | -1.43 | -2.98 | -4.94 | -4.38 | -4.6 | -2.82 | -5.46 | -5.68 | -5.22 | -18.8 | -5.71 | -6.36 | -4.57 | -1.85 | -5.51 | -5.07 | -5.35 | -9.66 | -6.71 | -6.76 | -3.64 | -6.8 | 1.53 | -3.52 | -3.62 | -0.19 | -4.76 | -4.85 | -1.5 | -2.24 | -2.75 |
| EPS Diluted
| -1.57 | -1.78 | -2.04 | -1.97 | -1.17 | -1.43 | -2.98 | -4.94 | -4.37 | -4.6 | -2.82 | -5.46 | -5.67 | -5.22 | -18.8 | -5.71 | -6.36 | -4.56 | -1.85 | -5.51 | -5.06 | -5.34 | -9.66 | -6.7 | -6.75 | -3.64 | -6.8 | 1.48 | -3.51 | -3.62 | -0.19 | -2.34 | -2.38 | -0.73 | -2.24 | -2.75 |
| EBITDA
| -269 | -215 | -230 | -200 | -77 | -121 | -375 | -586 | -502 | -476 | -232 | -576 | -596 | -519 | -2,091 | -510 | -610 | -407 | -49 | -452 | -402 | -383 | -782 | -575 | -587 | -322 | -585.055 | 128.793 | -309.614 | -243.1 | -5.8 | -201.349 | -199.133 | -54.467 | -247.497 | -211.476 |
| EBITDA Ratio
| -4.483 | -19.545 | -15.333 | -2.74 | -0.249 | -0.55 | -0.618 | -1.986 | -6.605 | -4.212 | -0.841 | -115.2 | -3.204 | -5.703 | -12.521 | -10.851 | -7.262 | -2.609 | -0.048 | -2.825 | -5.826 | -6.279 | -3.76 | -22.115 | -7.724 | -46 | -435.309 | 0.319 | -150.811 | -67.924 | -0.019 | 0 | -150.973 | -0.272 | -10.076 | -111.186 |